University of Minnesota researchers awarded NCI grant to study head and neck squamous cell carcinoma

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A University of Minnesota research team was awarded an R01 grant for their project, which aims to develop a profile analysis of oral cell DNA that may predict head and neck squamous cell carcinoma susceptibility in smokers and assess the role of alcohol intake.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login